2009 HCPCS Codes | Med Reference

Share

Med Reference

Filter

Privacy Policy Terms of Use Contact

Copyright © 2021 MedReference.org and . All Rights Reserved.

All content on this website ("the Site") is the property of . The collection and assembly of content on this Site are the exclusive property of and are protected by copyright and other intellectual property laws. We do not asset any claims of copyright for ICD 10 information or HCPCS Codes. ICD 10 ( International Statistical Classification of Diseases and Related Health Problems 10) is a copyright of the World Health Organization (WHO). HCPCS data is from the United States Centers for Medicare & Medicaid Services (CMS) and is from the 2019 HCPCS data edition. All HCPCS (Healthcare Common Procedure Coding System) codes are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). HCPCS procedure and descriptions are copyright to the American Medical Association (AMA). We claim no copyright over these. Inclusion of exlusion of a procedure, supply, product, or service does not imply any health insurance coverage or reimbursement policy. In some instances, brand names may appear in HCPCS descriptions. HCPCS has included these for indexing purposes only and their inclusion does not convey endorsement of any particular brand. We assume no responsibility or liability for any errors or omissions in the content of this site. Please use at your own risk.

Filters

Clear

Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).

Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).

https://medreference.org/i/q/medreference__hcpcs-codes?s=&h=&d=&o=&_n=25

Procedure

Description

Procedure: Albuterol non-comp unit
Description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg

Procedure: Levalbuterol non-comp unit
Description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

Procedure: Dornase alfa non-comp unit
Description: Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Procedure: Doxorubicin hcl injection
Description: Injection, doxorubicin hydrochloride, 10 mg

Procedure: Aldesleukin injection
Description: Injection, aldesleukin, per single use vial

Procedure: Arsenic trioxide injection
Description: Injection, arsenic trioxide, 1 mg

Procedure: Bleomycin sulfate injection
Description: Injection, bleomycin sulfate, 15 units

Procedure: Carboplatin injection
Description: Injection, carboplatin, 50 mg

Procedure: Carmustine injection
Description: Injection, carmustine, 100 mg

Procedure: Cytarabine liposome inj
Description: Injection, cytarabine liposome, 10 mg

Procedure: Cytarabine hcl 100 mg inj
Description: Injection, cytarabine, 100 mg

Procedure: Dactinomycin injection
Description: Injection, dactinomycin, 0.5 mg

Procedure: Daunorubicin injection
Description: Injection, daunorubicin, 10 mg

Procedure: Denileukin diftitox inj
Description: Injection, denileukin diftitox, 300 micrograms

Procedure: Diethylstilbestrol injection
Description: Injection, diethylstilbestrol diphosphate, 250 mg

Procedure: Etoposide injection
Description: Injection, etoposide, 10 mg

Procedure: Fluorouracil injection
Description: Injection, fluorouracil, 500 mg

Procedure: Irinotecan injection
Description: Injection, irinotecan, 20 mg

Procedure: Ixabepilone injection
Description: Injection, ixabepilone, 1 mg

Procedure: Mesna injection
Description: Injection, mesna, 200 mg

Procedure: Mechlorethamine hcl inj
Description: Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg

Procedure: Pegaspargase injection
Description: Injection, pegaspargase, per single dose vial

Procedure: Pentostatin injection
Description: Injection, pentostatin, 10 mg

Procedure: Streptozocin injection
Description: Injection, streptozocin, 1 gram

Procedure: Temsirolimus injection
Description: Injection, temsirolimus, 1 mg

Procedure: Thiotepa injection
Description: Injection, thiotepa, 15 mg

Procedure: Trastuzumab injection
Description: Injection, trastuzumab, 10 mg

Procedure: Valrubicin injection
Description: Injection, valrubicin, intravesical, 200 mg

Procedure: Vinblastine sulfate inj
Description: Injection, vinblastine sulfate, 1 mg

Procedure: Vinorelbine tartrate inj
Description: Injection, vinorelbine tartrate, 10 mg

Procedure: Porfimer sodium injection
Description: Injection, porfimer sodium, 75 mg

Procedure: Inpt implant pros dev,no cov
Description: Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage

Procedure: Initial preventive exam
Description: Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

Procedure: Corf related serv 15 mins ea
Description: Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)

Procedure: Grp psych partial hosp 45-50
Description: Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes

Procedure: Inter active grp psych parti
Description: Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes

Procedure: Pt rec ace/arb
Description: Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy

Procedure: Granisetron hcl 1 mg oral
Description: Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

Procedure: Skin substitute, nos
Description: Skin substitute, not otherwise specified

Procedure: Skin substitute graft
Description: Skin substitute used as a graft

JC

Procedure: Skin sub not used as a graft
Description: Skin substitute not used as a graft

JD

Procedure: Bid under round 1 dmepos cb
Description: Bid under round one of the dmepos competitive bidding program for use with non-competitive bid base equipment

KE

Procedure: Dmepos mailorder comp bid
Description: Dmepos item delivered via mail

KL

Procedure: Surgery, wrong body part
Description: Surgical or other invasive procedure on wrong body part

PA

Procedure: Surgery, wrong patient
Description: Surgical or other invasive procedure on wrong patient

PB

Procedure: Wrong surgery on patient
Description: Wrong surgery or other invasive procedure on patient

PC

Procedure: Pet tumor init tx strat
Description: Positron emission tomography (pet) or pet/computed tomography (ct) to inform the initial treatment strategy of tumors that are biopsy proven or strongly suspected of being cancerous based on other diagnostic testing

PI

Procedure: Pet tumor subsq tx strategy
Description: Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy

PS

Procedure: Furnish full compliance rems
Description: Furnished in full compliance with fda-mandated risk evaluation and mitigation strategy (rems)

RE

Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).

Was this site helpful to you? We would very much appreciate you whitelisting us or using this link when you shop on Amazon (no impact on your order).